Bronchitis Treatment Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Bronchitis Treatment Market to 2027 - Global Analysis and Forecasts by Treatment (Drugs, Oxygen Therapy); Class of Drugs (Antibiotics, Bronchodilators, Anti-inflammatory Drugs, Mucolytics); End User (Hospitals, Clinics, Drug Stores) and Geography

Report Code: TIPRE00004063 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Bronchitis is a respiratory disease that involves inflammation of the bronchi in the lungs. So, bronchitis is basically an inflammation of the lining of bronchial tubes which carry air to and fro the lungs. Some of the common signs and symptoms of bronchitis contain fatigue, cough, chest discomfort, shortness of breath, production of mucus, etc. The primary treatment for acute bronchitis is symptomatic treatment, though, if the symptoms persists, antimicrobial therapy is recommended by the physicians. Mostly antibacterial such as clarithromycin or azithromycin are administered.

MARKET DYNAMICS
The bronchitis treatment market is expected to grow during the forecast period due to sedentary lifestyle, addiction to cigarette smoke and chemical pollutants, guidelines from the World Health Organization (WHO), rise in morbidity & mortality associated with bronchitis and stringent regulations to pollutant emission control. However, stringent regulatory scenario and patent expiry of key drugs are likely to hamper the growth of the market in the forecast period.

MARKET SCOPE
The "Global Bronchitis Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of enteral feeding formulas market with detailed market segmentation by treatment, class of drugs, end user and geography. The global bronchitis treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading enteral feeding formulas market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global bronchitis treatment market is segmented on the basis of treatment, class of drugs and end user. Based on treatment the market is classified as drugs and oxygen therapy. On the basis of class of drugs the market is classified as antibiotics, bronchodilators, anti-inflammatory drugs and mucolytics. On the basis of end user the bronchitis treatment market is classified as hospitals, clinics and drug stores.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global bronchitis treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The bronchitis treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting bronchitis treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the bronchitis treatment market in these regions.

MARKET PLAYERS
The reports cover key developments in the bronchitis treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from bronchitis treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for bronchitis treatment market in the global market. Below mentioned is the list of few companies engaged in the bronchitis treatment market.

The report also includes the profiles of key bronchitis treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Boehringer Ingelheim International GmbH
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Sanofi
  • MELINTA THERAPEUTICS, INC.
  • AstraZeneca
  • Novartis AG
  • F. Hoffmann-La Roche Ltd.
  • DBV Technologies
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Bronchitis Treatment Market - By Treatment
1.3.2 Bronchitis Treatment Market - By Class of Drugs
1.3.3 Bronchitis Treatment Market - By End User
1.3.4 Bronchitis Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. BRONCHITIS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BRONCHITIS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BRONCHITIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. BRONCHITIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. BRONCHITIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BRONCHITIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT
7.1. OVERVIEW
7.2. TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. DRUGS
7.3.1. Overview
7.3.2. Drugs Market Forecast and Analysis
7.4. OXYGEN THERAPY
7.4.1. Overview
7.4.2. Oxygen Therapy Market Forecast and Analysis
8. BRONCHITIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - CLASS OF DRUGS
8.1. OVERVIEW
8.2. CLASS OF DRUGS MARKET FORECASTS AND ANALYSIS
8.3. ANTIBIOTICS
8.3.1. Overview
8.3.2. Antibiotics Market Forecast and Analysis
8.4. BRONCHODILATORS
8.4.1. Overview
8.4.2. Bronchodilators Market Forecast and Analysis
8.5. ANTI-INFLAMMATORY DRUGS
8.5.1. Overview
8.5.2. Anti-inflammatory Drugs Market Forecast and Analysis
8.6. MUCOLYTICS
8.6.1. Overview
8.6.2. Mucolytics Market Forecast and Analysis
9. BRONCHITIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. DRUG STORES
9.5.1. Overview
9.5.2. Drug Stores Market Forecast and Analysis
10. BRONCHITIS TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Bronchitis Treatment Market Overview
10.1.2 North America Bronchitis Treatment Market Forecasts and Analysis
10.1.3 North America Bronchitis Treatment Market Forecasts and Analysis - By Treatment
10.1.4 North America Bronchitis Treatment Market Forecasts and Analysis - By Class of Drugs
10.1.5 North America Bronchitis Treatment Market Forecasts and Analysis - By End User
10.1.6 North America Bronchitis Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Bronchitis Treatment Market
10.1.6.1.1 United States Bronchitis Treatment Market by Treatment
10.1.6.1.2 United States Bronchitis Treatment Market by Class of Drugs
10.1.6.1.3 United States Bronchitis Treatment Market by End User
10.1.6.2 Canada Bronchitis Treatment Market
10.1.6.2.1 Canada Bronchitis Treatment Market by Treatment
10.1.6.2.2 Canada Bronchitis Treatment Market by Class of Drugs
10.1.6.2.3 Canada Bronchitis Treatment Market by End User
10.1.6.3 Mexico Bronchitis Treatment Market
10.1.6.3.1 Mexico Bronchitis Treatment Market by Treatment
10.1.6.3.2 Mexico Bronchitis Treatment Market by Class of Drugs
10.1.6.3.3 Mexico Bronchitis Treatment Market by End User
10.2. EUROPE
10.2.1 Europe Bronchitis Treatment Market Overview
10.2.2 Europe Bronchitis Treatment Market Forecasts and Analysis
10.2.3 Europe Bronchitis Treatment Market Forecasts and Analysis - By Treatment
10.2.4 Europe Bronchitis Treatment Market Forecasts and Analysis - By Class of Drugs
10.2.5 Europe Bronchitis Treatment Market Forecasts and Analysis - By End User
10.2.6 Europe Bronchitis Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Bronchitis Treatment Market
10.2.6.1.1 Germany Bronchitis Treatment Market by Treatment
10.2.6.1.2 Germany Bronchitis Treatment Market by Class of Drugs
10.2.6.1.3 Germany Bronchitis Treatment Market by End User
10.2.6.2 France Bronchitis Treatment Market
10.2.6.2.1 France Bronchitis Treatment Market by Treatment
10.2.6.2.2 France Bronchitis Treatment Market by Class of Drugs
10.2.6.2.3 France Bronchitis Treatment Market by End User
10.2.6.3 Italy Bronchitis Treatment Market
10.2.6.3.1 Italy Bronchitis Treatment Market by Treatment
10.2.6.3.2 Italy Bronchitis Treatment Market by Class of Drugs
10.2.6.3.3 Italy Bronchitis Treatment Market by End User
10.2.6.4 Spain Bronchitis Treatment Market
10.2.6.4.1 Spain Bronchitis Treatment Market by Treatment
10.2.6.4.2 Spain Bronchitis Treatment Market by Class of Drugs
10.2.6.4.3 Spain Bronchitis Treatment Market by End User
10.2.6.5 United Kingdom Bronchitis Treatment Market
10.2.6.5.1 United Kingdom Bronchitis Treatment Market by Treatment
10.2.6.5.2 United Kingdom Bronchitis Treatment Market by Class of Drugs
10.2.6.5.3 United Kingdom Bronchitis Treatment Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Bronchitis Treatment Market Overview
10.3.2 Asia-Pacific Bronchitis Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Bronchitis Treatment Market Forecasts and Analysis - By Treatment
10.3.4 Asia-Pacific Bronchitis Treatment Market Forecasts and Analysis - By Class of Drugs
10.3.5 Asia-Pacific Bronchitis Treatment Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Bronchitis Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Bronchitis Treatment Market
10.3.6.1.1 Australia Bronchitis Treatment Market by Treatment
10.3.6.1.2 Australia Bronchitis Treatment Market by Class of Drugs
10.3.6.1.3 Australia Bronchitis Treatment Market by End User
10.3.6.2 China Bronchitis Treatment Market
10.3.6.2.1 China Bronchitis Treatment Market by Treatment
10.3.6.2.2 China Bronchitis Treatment Market by Class of Drugs
10.3.6.2.3 China Bronchitis Treatment Market by End User
10.3.6.3 India Bronchitis Treatment Market
10.3.6.3.1 India Bronchitis Treatment Market by Treatment
10.3.6.3.2 India Bronchitis Treatment Market by Class of Drugs
10.3.6.3.3 India Bronchitis Treatment Market by End User
10.3.6.4 Japan Bronchitis Treatment Market
10.3.6.4.1 Japan Bronchitis Treatment Market by Treatment
10.3.6.4.2 Japan Bronchitis Treatment Market by Class of Drugs
10.3.6.4.3 Japan Bronchitis Treatment Market by End User
10.3.6.5 South Korea Bronchitis Treatment Market
10.3.6.5.1 South Korea Bronchitis Treatment Market by Treatment
10.3.6.5.2 South Korea Bronchitis Treatment Market by Class of Drugs
10.3.6.5.3 South Korea Bronchitis Treatment Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Bronchitis Treatment Market Overview
10.4.2 Middle East and Africa Bronchitis Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Bronchitis Treatment Market Forecasts and Analysis - By Treatment
10.4.4 Middle East and Africa Bronchitis Treatment Market Forecasts and Analysis - By Class of Drugs
10.4.5 Middle East and Africa Bronchitis Treatment Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Bronchitis Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Bronchitis Treatment Market
10.4.6.1.1 South Africa Bronchitis Treatment Market by Treatment
10.4.6.1.2 South Africa Bronchitis Treatment Market by Class of Drugs
10.4.6.1.3 South Africa Bronchitis Treatment Market by End User
10.4.6.2 Saudi Arabia Bronchitis Treatment Market
10.4.6.2.1 Saudi Arabia Bronchitis Treatment Market by Treatment
10.4.6.2.2 Saudi Arabia Bronchitis Treatment Market by Class of Drugs
10.4.6.2.3 Saudi Arabia Bronchitis Treatment Market by End User
10.4.6.3 U.A.E Bronchitis Treatment Market
10.4.6.3.1 U.A.E Bronchitis Treatment Market by Treatment
10.4.6.3.2 U.A.E Bronchitis Treatment Market by Class of Drugs
10.4.6.3.3 U.A.E Bronchitis Treatment Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Bronchitis Treatment Market Overview
10.5.2 South and Central America Bronchitis Treatment Market Forecasts and Analysis
10.5.3 South and Central America Bronchitis Treatment Market Forecasts and Analysis - By Treatment
10.5.4 South and Central America Bronchitis Treatment Market Forecasts and Analysis - By Class of Drugs
10.5.5 South and Central America Bronchitis Treatment Market Forecasts and Analysis - By End User
10.5.6 South and Central America Bronchitis Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Bronchitis Treatment Market
10.5.6.1.1 Brazil Bronchitis Treatment Market by Treatment
10.5.6.1.2 Brazil Bronchitis Treatment Market by Class of Drugs
10.5.6.1.3 Brazil Bronchitis Treatment Market by End User
10.5.6.2 Argentina Bronchitis Treatment Market
10.5.6.2.1 Argentina Bronchitis Treatment Market by Treatment
10.5.6.2.2 Argentina Bronchitis Treatment Market by Class of Drugs
10.5.6.2.3 Argentina Bronchitis Treatment Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BRONCHITIS TREATMENT MARKET, KEY COMPANY PROFILES
12.1. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. DR. REDDY’S LABORATORIES LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PFIZER INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SANOFI
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MELINTA THERAPEUTICS, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ASTRAZENECA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. F. HOFFMANN-LA ROCHE LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. DBV TECHNOLOGIES
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Boehringer Ingelheim International GmbH
2. Dr. Reddy's Laboratories Ltd.
3. GlaxoSmithKline plc
4. Pfizer Inc.
5. Sanofi
6. MELINTA THERAPEUTICS, INC.
7. AstraZeneca
8. Novartis AG
9. F. Hoffmann-La Roche Ltd.
10. DBV Technologies
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book